Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,344,793
-$134,911 QoQ
Shares Held
136,197
-3.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#114
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. NVS ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,361,825 | $172,052,970 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,344,793 | 136,197 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,479,704 | 140,620 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $16,547,983 | 120,026 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $15,611,809 | 121,739 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $13,952,331 | 115,299 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $12,165,812 | 109,130 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,983,087 | 112,867 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $19,081,242 | 165,895 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,823,958 | 167,424 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $16,952,706 | 175,258 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $21,429,165 | 212,233 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $26,749,759 | 262,613 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,073,565 | 278,204 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $27,664,124 | 300,697 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $30,432,023 | 335,450 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $55,541,190 | 730,709 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $69,213,163 | 818,800 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $72,146,558 | 822,183 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $75,846,898 | 867,119 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $83,592,080 | 1,022,158 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $97,397,421 | 1,067,486 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $109,195,485 | 1,277,439 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $137,326,054 | 1,454,263 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $191,650,012 | 2,203,887 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $217,673,289 | 2,492,252 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $169,923,347 | 2,060,926 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||